-
Mashup Score: 0Jennifer Woyach, MD, Reflects on the Liso-Cel Approval for CLL | Blood Cancers Today - 8 hour(s) ago
Liso-cel was approved in March 2024 by the FDA for patients with relapsed or refractory CLL.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 2Mistaken Identity: Using Bone Scintigraphy to Diagnose Cardiac Amyloidosis in Patients With a Monoclonal Gammopathy - 8 hour(s) ago
Central Illustration
Source: www.jacc.orgCategories: General Medicine News, Partners & KOLsTweet-
Here's a #JACCCardioOnc clinical case challenge about a 63y/o man w/ a history of bilateral carpal tunnel syndrome presented to an outside hospital w/ dyspnea on exertion, positional lightheadedness & chest pain https://t.co/cCjbyRU9cB @PennThalheimer @KMAlexanderMD #Amyloidosis https://t.co/obGatXp4CO
-
-
Mashup Score: 0John Fetterman to receive top Jewish college's highest award for his stance on Israel - 8 hour(s) ago
Sen. John Fetterman, D-Pa., will receive the highest honor awarded by a top American Jewish university, Yeshiva University in New York City, during its Wednesday commencement.
Source: www.yahoo.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 7Forging A Path Forward for Global Mental Health - 9 hour(s) ago
And its importance in advancing USAID’s global development work
Source: medium.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 0ECO 24: EASL-EASD-EASO Practice Guidelines for MAFLD - 9 hour(s) ago
ECO 2024 — Prof Sven Francque (University of Antwerp, BE) joins us to talk about the new EASL-EASD-EASO Practice Guidelines for MAFLD.In this interview, Prof Francque highlights some of the
Source: www.radcliffecardiology.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 0
Russian strikes on a crowded DIY hardware store in the Ukrainian city of Kharkiv on Saturday killed at least two people, wounded many more, and triggered a huge blaze that fire crews were battling to contain, regional officials said.
Source: www.reuters.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 2'The HemOnc Pulse' Live: Unpacking Bispecifics | Blood Cancers Today - 12 hour(s) ago
Michael Bishop MD; Aaron Goodman, MD; and Rafael Fonseca, MD, discuss bispecifics in hematologic malignancies.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 0How to Discuss a HER2-Positive Breast Cancer Diagnosis With Patients | Cancer Nursing Today - 12 hour(s) ago
A roundtable panel discusses how to help patients understand breast cancer subtypes, treatment options, and survival outcomes. Learn what expert nurses and physicians recommend.
Source: cancernursingtoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 0Exercise pattern study reveals lower Parkinson's risk for weekend warriors and regulars alike - 12 hour(s) ago
A recent study in npj Digital Medicine found that both “weekend warrior” and regular exercise patterns significantly reduce Parkinson’s disease (PD) risk. The findings suggest exercise duration is more critical than frequency in mitigating PD risk.
Source: www.news-medical.netCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 0Episode 104: Colorectal Cancer Series, Pt. 6 - Colorectal Cancer Pharmacology — The Fellow On Call - 13 hour(s) ago
Episode 104: Colorectal Cancer Series, Pt. 6 – Colorectal Cancer Pharmacology We have another guest joining us this week! Dr. Allison Schepers, PharmD, BCOP is a Clinical Pharmacist Specialist at the Rogel uCancer Center at the University of Michigan where she focuses on GI, GU, and Thoracic malign
Source: www.thefellowoncall.comCategories: General Medicine News, Partners & KOLsTweet
Jennifer Woyach, MD, of @OSUCCC_James, stopped by BCT to reflect on the @US_FDA approval of liso-cel for the treatment of #CLL. 📺 Hear what she has to say: https://t.co/dqooenrbx5 https://t.co/ZtU5vE9U5f